| Lobbyist Public Search |
|
Records prior to registration year 2005 are not available online.
Contact the Lobbyist Division here for assistance.
|
Search data is collected from registration records and disclosure reports
submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining
lobbying services to register annually, and submit disclosure reports twice a year.
|
| Your comments are welcome:
submit feedback
|
|
| Disclosure reporting details |
|
Back to search detail summary
|
|
:
01/01/2020 - 06/30/2020
|
|
Authorizing Officer name
|
Pat
A.
Cerundolo
|
|
Title
|
Partner
|
|
Business name
|
Foley Hoag LLP
|
|
Address
|
155 Seaport Blvd
|
|
City, state, zip code
|
Boston, MA 02110
|
|
Country
|
USA
|
|
Phone
|
617-832-1252
|
|
|
|
|
Client Compensation
|
| Vertex Pharmaceuticals, Incorporated |
$0.00
|
| Gilead Sciences, Inc. |
$0.00
|
| Amgen, Inc. |
$0.00
|
| Massachusetts Biotechnology Council |
$60,011.00
|
| American Chemistry Council |
$25,000.00
|
| bluebird bio |
$10,000.00
|
| BROOKFIELD POWER US ASSET MANAGEMENT LLC |
$18,000.00
|
| Total salaries received |
$113,011.00
|
|
|
| |
|
Compensation/Salaries Paid
|
|
Dean Richlin
|
$0.00
|
|
Carol J. Holahan
|
$43,000.00
|
|
Pat A. Cerundolo
|
$70,011.00
|
| Total salaries paid |
$113,011.00
|
|
| |
|
Activities, Bill Numbers and Titles
|
| No activities, bill numbers or bill titles were disclosed for this reporting period. |
|
| |
|
Operating Expenses
|
| No operating expenses were filed for this disclosure reporting period. |
|
| |
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|
| |
|
Lobbyist: Carol J. Holahan
|
|
Client:
American Chemistry Council
|
|
|
|
Executive
|
Other
|
Policies and procedures of TURA Scientific Advisory Board, the TURA Advisory Committee, and the TURA Administrative Council related to compliance with Toxic Uses Reduction Act, including procedures related to listing of hazardous substances, fee structure, and mandatory reporting requirements.
|
Neutral
|
$25,000.00
|
N/A
|
| | | |
Total amount
|
$25,000.00
| |
|
|
Lobbyist: Carol J. Holahan
|
|
Client:
BROOKFIELD POWER US ASSET MANAGEMENT LLC
|
|
|
|
Executive
|
Other
|
Clean energy policies under consideration by the Department of Energy Resources, including adopting of a clean peak energy standard, renewable energy certificates, and the effect of re-licensing and re-powering of qualifying renewable energy facilities.
|
Neutral
|
$18,000.00
|
N/A
|
| | | |
Total amount
|
$18,000.00
| |
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|
|
Lobbyist: Pat A. Cerundolo
|
|
Client:
Massachusetts Biotechnology Council
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $60,011.00
|
|
Senate Bill
|
2397
|
An Act Relative to Pharmaceutical Access, Cost, and Transparency
|
Oppose
|
$0.00
|
N/A
|
|
Executive
|
Other
|
Monitoring Health Policy Commission implementation of 958 CMR 12.00, Drug Pricing
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2409
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Monitoring EOHHS implementation of 101 CMR 801.00: Drug Manufacturer Negotiations and Accountability
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: Pat A. Cerundolo
|
|
Executive
|
MassHealth
|
State Medicaid (MassHealth) coverage and payment policies for gene therapy.
|
Neutral
|
$10,000.00
|
N/A
|
| | | |
Total amount
|
$10,000.00
| |
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| 02/06/2020 | Pat A. Cerundolo |
Travel
|
Boston Cab
|
|
$11.00
|
| 02/06/2020 | Pat A. Cerundolo |
Travel
|
Boston Cab
|
|
$11.00
|
| | | | | Total amount |
$22.00
|
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|
|
|
|
|